Oklo (NYSE:OKLO) Shares Up 7.4% - What's Next?
Oklo (NYSE:OKLO) stock rose 7.4% on Wednesday, with trading volume slightly below average. The company faces risks due to a recent earnings miss and a negative EPS outlook, with insiders being net sellers. Oklo specializes in advanced nuclear microreactors and maintains a "Moderate Buy" consensus rating from analysts, who have set an average price target of $84.30.
Oklo Regulatory Wins Spark Questions On Commercial Timing And Valuation
Oklo has recently secured three key regulatory approvals for its Aurora Powerhouse microreactor and Atomic Alchemy's Groves Isotopes Test Reactor, moving the company closer to commercial activity. Despite these wins, the stock has seen declines recently, suggesting investors are reassessing commercialization timing and risks. The company remains loss-making with significant funding risk, prompting investors to monitor further regulatory milestones, customer contracts, and revenue projections.
Oklo Inc. (NYSE:OKLO) Receives Average Recommendation of "Moderate Buy" from Brokerages
Oklo Inc. (NYSE:OKLO) has received an average "Moderate Buy" rating from 19 analysts, with an average 12-month price target of $84.30, despite some major firms trimming their targets. The company has seen significant insider selling, totaling over $61 million in the last three months, and remains loss-making, having missed recent EPS expectations. However, institutions like ARK Invest have shown renewed interest in the advanced nuclear microreactor company, which aims to provide carbon-free power.
A Look At Oklo (OKLO) Valuation After Recent Share Price Pullback
Oklo (OKLO) has experienced a significant share price pullback recently, declining 16.3% in the last month and 49.0% over three months, despite a strong 122.34% one-year return. With a valuation of US$8.4 billion and no current revenue, the article questions if the stock's future growth is already priced in or if the correction presents a buying opportunity. While one narrative suggests Oklo is 56.5% undervalued with a fair value of $112, driven by expected rapid growth and a high future P/E, another view based on P/B ratio indicates it appears expensive.
Secure Asset Management Cuts Stake in Oklo Inc.
Secure Asset Management LLC significantly reduced its stake in Oklo Inc. by over 75% in the fourth quarter of 2025, selling more than 27,000 shares. This reduction, amid Oklo's fluctuating stock price, may indicate broader investor uncertainty regarding the nuclear tech company's future or the small modular reactor (SMR) industry in general. Despite this, Oklo remains a key player in the emerging carbon-free nuclear technology sector.
Oklo (OKLO) Stock: Top Execs Dump $21M in Shares Amid Cramer Criticism and Earnings Disappointment
Oklo's top executives, including CEO Jacob DeWitte and COO Caroline Cochran, sold over $21 million in company shares on April 1st through pre-scheduled trading arrangements, with DeWitte's selling spree starting earlier in the year. This comes as CNBC's Jim Cramer has publicly questioned the nuclear startup's commercial viability and potential for near-term revenue. The company also reported a quarterly loss of $0.27 per share, significantly missing Wall Street's expectations, leading analysts to trim their price targets despite maintaining a "Moderate Buy" consensus.
Oklo (NYSE:OKLO) Shares Up 1.3% - Should You Buy?
Oklo (NYSE:OKLO) shares rose 1.3% to $48.75 on Monday, trading below moving averages despite a "Moderate Buy" consensus from analysts. The company missed its quarterly EPS estimates and has seen significant insider selling, including shares sold by its CEO. Institutional investors have increased their holdings, while analysts' price targets vary widely.
Is Oklo Inc. (OKLO) A Good Stock To Buy Now?
Oklo Inc. (OKLO) is presented as a high-risk, high-reward investment opportunity in the advanced nuclear energy sector, particularly appealing due to its focus on microreactors for AI-driven data centers. Despite being pre-commercial and currently revenue-minimal, the company is poised to benefit from decarbonization goals, rising global power consumption, and significant policy tailwinds from the U.S. Department of Energy. Its potential for substantial long-term upside is contingent on successful execution of regulatory approvals and plant deployment.
Jim Cramer Says Oklo “Has Very Little Prospects for Making Any Money Any Time in the Future”
Jim Cramer has expressed a negative outlook on Oklo Inc. (NYSE: OKLO), stating the company has "very little prospects for making any money any time in the future." He advised callers to sell the stock, emphasizing that while its technology might seem promising, Oklo is not yet a commercial enterprise in nuclear power. Cramer compared Oklo to established companies like GE Vernova, which he says knows how to build power plants, unlike newer firms still learning.
Can Oklo's (OKLO) Expanded Blykalla Partnership Reframe Its Advanced Nuclear Execution and Validation Path?
Oklo Inc. and Sweden’s Blykalla AB have expanded their partnership, with Blykalla committing US$100-200 million and 30-40 engineers to support Oklo's U.S. Department of Energy-authorized fast reactor pilot project. This collaboration is expected to provide Oklo with access to capital, engineering talent, and technical validation, potentially influencing its advanced nuclear ambitions and investment narrative. The partnership, alongside Oklo’s agreement with Meta, is crucial for the company's progression from pilot projects to commercial power and isotope sales, though risks like schedule slippage and sustained losses remain.
Oklo (NYSE:OKLO) CEO Jacob Dewitte Sells 140,000 Shares
Oklo (NYSE:OKLO) CEO Jacob Dewitte sold 140,000 shares of the company's stock on April 1st for over $7 million, reducing his stake by 17.58%. This is part of a larger trend of significant insider selling by Dewitte since January, with prior sales at much higher prices. The company's shares are currently trading near $48.15, with analysts having a "Moderate Buy" consensus and an average price target of $84.30, despite a recent earnings per share miss.
Wealth Firm Reduces Stake in Oklo Nuclear Startup
Wealth Enhancement Advisory Services reduced its stake in Oklo Inc., an advanced nuclear microreactor company, by selling over 30,000 shares in the fourth quarter. This move reflects potential shifts in investor sentiment surrounding Oklo's technology and the evolving small modular reactor market. The firm now holds 28,593 shares of Oklo, valued at approximately $2.05 million.
Mixed options sentiment in Oklo Inc with shares up 0.56%
Oklo Inc (OKLO) shares rose 0.56%, closing at $48.34, amid mixed options sentiment. Options trading volume was average, with puts outnumbering calls (put/call ratio of 1.13), and implied volatility dropped to its lowest 10% range over the past year. This suggests an expected daily move of $2.59, and an increased demand for downside protection.
Nuclear's Pullback: A Generational Buying Opportunity?
Despite a recent market downturn in nuclear stocks, the sector is experiencing strong long-term tailwinds driven by energy security, decarbonization mandates, and surging electricity demand from AI and data centers. This disconnect presents a potential generational buying opportunity across the nuclear value chain. Investors can consider a diversified approach, from uranium miners and existing utility operators to companies enabling growth and pioneering future small modular reactor technologies.
Can Oklo's (OKLO) Expanded Blykalla Partnership Reframe Its Advanced Nuclear Execution and Validation Path?
Oklo Inc. and Sweden’s Blykalla AB have expanded their partnership, with Blykalla committing US$100–200 million and 30–40 engineers to support Oklo’s fast reactor pilot project. This collaboration is expected to deepen Oklo’s access to capital, engineering talent, and technical validation, integrating Blykalla’s lead-cooled SEALER technology. While strengthening Oklo's path towards commercial power and isotope sales, particularly with its DOE reactor pilot and NRC licensing progress, investors are cautioned about the company's reliance on evolving U.S. policy frameworks.
Craig‑Hallum Maintains Hold on Oklo Inc. (OKLO) March 2026
Craig-Hallum has maintained a "Hold" rating on Oklo Inc. (OKLO) but lowered its price target to $71, citing higher expected operating expenses and capital spending. This update suggests tempered growth expectations and near-term caution for investors, as reflected in the stock's -19.52% move since the report. Given limited analyst coverage on Oklo, this single-firm update carries significant weight on market sentiment, though Meyka AI still rates OKLO with a grade of B.
Oklo Inc (OKLO) rated buy on nuclear energy growth
The article states that Oklo Inc (OKLO) has received a "buy" rating, indicating a positive outlook on the company. This rating is attributed to the anticipated growth in the nuclear energy sector, suggesting that Oklo is well-positioned to benefit from this industry trend.
Oklo And Blykalla Expand ‘Transatlantic Partnership’ On Fast Reactor Commercialisation
US advanced reactor company Oklo and Sweden-based Blykalla have expanded their transatlantic partnership. This collaboration aims to broaden efforts on fast reactor commercialisation. The companies plan to jointly invest up to $200 million in this initiative.
SG Americas Securities LLC Grows Stock Holdings in Oklo Inc. $OKLO
SG Americas Securities LLC significantly increased its stake in Oklo Inc. during Q4, adding 85,419 shares to reach a total of 120,752 shares valued at $8.67 million. Despite this institutional buying, the company has seen substantial insider selling, with the CFO and CEO selling shares worth millions. Oklo currently holds a "Moderate Buy" consensus rating from analysts, but reported an earnings per share miss in its last quarter.
Oklo (OKLO) Advances Aurora Project Under DOE Risk Reduction Program
Oklo Inc. is advancing its Aurora project at Idaho National Laboratory under the Department of Energy's Risk Reduction Pilot Program, while also securing a prepayment-for-power arrangement with Meta for a proposed facility in Ohio. Craig-Hallum recently reduced its price target for OKLO to $71 from $87, maintaining a Hold rating due to revised estimates incorporating higher operating and capital expenditures. The firm noted Oklo's vertically integrated infrastructure and its future-oriented nuclear technology.
Oklo (OKLO) Valuation Check After Meta Power Deal And Expanded Blykalla Reactor Partnership
Oklo (OKLO) is gaining attention after securing a prepaid power deal with Meta and expanding its partnership with Blykalla AB, despite recent share price declines. Although the company is currently unprofitable and has zero revenue, a narrative suggests it is significantly undervalued, with a fair value of $112.13 per share compared to its last close of $45.58. This valuation is based on an ambitious growth and profitability forecast for Oklo's vertically integrated fuel strategy, though it faces risks related to operating losses and reliance on evolving federal programs.
Oklo Inc. Navigates Strategic Growth Amid High-Volatility 9% Market Correction
Oklo Inc., a nuclear energy startup, is experiencing market turbulence despite achieving significant commercial and regulatory milestones. While the company secured its first U.S. Nuclear Regulatory Commission license for its subsidiary Atomic Alchemy, allowing it to generate revenue from isotope sales, its stock has sharply declined by over 9%, ending at $45.58 from a peak of $193. The company reported a net loss of $105.7 million for 2025 and plans substantial investments in 2026, though bolstered by a $1.4 billion cash buffer, with insider selling raising investor concern.
Meta Secures Nuclear Power Deals with Oklo and Vistra for Energy Needs - News and Statistics
Meta is investing in nuclear power from Oklo (OKLO) and Vistra (VST) to meet the increasing energy demands of its AI and data center operations. Meta's agreement with Oklo involves prepayment for future electricity to fund the construction of its first reactor, while a deal with Vistra secures power from existing and potentially upgraded nuclear plants. These strategic partnerships aim to ensure a stable and powerful energy supply for Meta's advanced computational needs.
Oklo, Blykalla to Expand Strategic Partnership Through U.S. Investment and Collaboration
Oklo Inc. and Blykalla AB, advanced nuclear technology companies from the U.S. and Sweden, announced an expanded strategic partnership to broaden collaboration on fast reactor commercialization. Blykalla plans to invest $100-200 million and commit 30-40 engineers in the U.S. for workstreams including supporting Oklo's reactor pilot project and exploring fast-neutron irradiation testing. This collaboration aims to accelerate technology development and deployment of advanced nuclear reactors.
Oklo, Blykalla to Expand Strategic Partnership Through U.S. Investment and Collaboration
Oklo Inc. and Blykalla AB, advanced nuclear technology companies from the U.S. and Sweden, respectively, announced an expanded strategic
Exchange Traded Concepts LLC Grows Stock Holdings in Oklo Inc. $OKLO
Exchange Traded Concepts LLC significantly increased its holdings in Oklo Inc. during Q4, acquiring over 48,000 additional shares. This increase comes amidst conflicting analyst sentiment, with some upgrading their ratings while others lowered price targets. Oklo has shown recent positive developments including regulatory progress for its Aurora reactor and the acquisition of Atomic Alchemy to diversify revenue.
UBS cuts Oklo stock price target on execution risk, cost concerns
UBS has significantly lowered its price target for Oklo Inc. (NYSE:OKLO) from $95 to $60, while maintaining a Neutral rating on the stock, citing increased near-term execution risk and potential for higher capital spending and cost overruns on nuclear projects. The revised target reflects a reduced EV/EBITDA multiple which aligns with broader nuclear industry averages. Despite the price target reduction, Oklo holds more cash than debt and has had other recent analyst adjustments, some positive regarding its Aurora reactor, while others also cite capital needs concerns.
UBS Maintains Oklo Inc(OKLO.US) With Hold Rating, Cuts Target Price to $60
UBS analyst Jon Windham has reiterated a "hold" rating for Oklo Inc (OKLO.US) but significantly reduced the target price from $95 to $60. According to TipRanks data, Windham has a 52.8% success rate and a 9.8% average return over the past year. TipRanks provides independent analysis of financial analysts' performance based on their recommendations.
Craig-Hallum Maintains Hold on Oklo Inc. (OKLO) March 2026
Craig-Hallum has maintained a "Hold" rating on Oklo Inc. (OKLO) but lowered its price target to $71, citing higher operating expenses and capital expenditures. This move led to a 7.33% drop in Oklo's share price. Meyka AI rates OKLO with a B grade, advising investors to consider the lowered price target as a signal for caution and to monitor the company's cost guidance.
How Investors Are Reacting To Oklo (OKLO) Wider 2025 Loss And New DOE Aurora Reactor Agreements
Oklo Inc. reported a wider net loss of US$105.66 million for 2025 but simultaneously secured crucial U.S. Department of Energy (DOE) agreements for its Aurora reactor and fuel fabrication facility at Idaho National Laboratory. These agreements are pivotal for advancing the company's first-of-a-kind deployment under DOE's pilot programs, although significant capital needs and execution risks remain for its build-own-operate model. While some analysts project substantial revenue and a significant upside to its stock price by 2029, the company is still pre-revenue and heavily reliant on federal support to transition to commercial operations.
Oklo Co-Founder and CEO Appointed to Serve on President’s Council of Advisors on Science and Technology
Oklo Inc. announced that its co-founder and CEO, Jacob DeWitte, has been appointed by U.S. President Donald J. Trump to the President’s Council of Advisors on Science and Technology (PCAST). DeWitte, who co-founded Oklo 13 years ago, brings expertise in advanced nuclear technology development to the Council. He joins a distinguished group of leaders from various technology and business sectors, aiming to strengthen American leadership in science and technology and support a clean energy future.
Oklo CEO Jacob DeWitte appointed to White House science council
Oklo Inc. CEO and co-founder Jacob DeWitte has been appointed to the President’s Council of Advisors on Science and Technology. DeWitte, who co-founded Oklo 13 years ago, brings expertise in advanced nuclear technology, and will collaborate with other leaders to strengthen American leadership in science and technology. Oklo's stock has shown volatility, down 54% over six months but up 91% over the past year, with a $9.6 billion market capitalization despite not yet being profitable.
Trump picks Oklo’s nuclear startup CEO for White House science panel
Oklo Inc. CEO and co-founder Jacob DeWitte has been appointed by President Donald J. Trump to serve on the President’s Council of Advisors on Science and Technology (PCAST). DeWitte, whose company focuses on advanced nuclear technology for clean energy, expressed his honor to join the council and contribute to strengthening American leadership in science and technology. He will join other prominent leaders from various technology and business sectors on PCAST.
Oklo Expands Nuclear Waste And Isotope Platform While Shares Trail Targets
Oklo (NYSE:OKLO) is expanding its nuclear energy platform by making progress in nuclear waste management and acquiring Atomic Alchemy to add medical and industrial isotope production capabilities. These advancements broaden Oklo's business beyond compact advanced reactors, diversifying its potential revenue streams into energy and healthcare. Despite these developments, Oklo currently has no revenue, is loss-making, and its shares are trading significantly below analyst targets, indicating execution risk and potential for further dilution.
Oklo Lowers Price Targets Amid Higher Capex
Goldman Sachs and B. Riley have adjusted their price targets for Oklo Inc. due to higher projected capital expenditures. Goldman Sachs cut its target to $65, while B. Riley lowered its target to $92, both citing the company's increased 2026 capital expenditure forecast and current liquidity to support 2028 reactor development.
Should You Buy Oklo Stock While It's Below $55?
Oklo (NYSE: OKLO) is developing small, modular nuclear power plants and recently secured a deal with Meta Platforms, fueling interest in its stock. Despite a significant drop from its 2025 high, the company is still in its early stages with its first powerhouse projected for 2028 and the Meta project in Ohio by 2034. Analysts caution against the stock's current high valuation, as meaningful revenue is years away, suggesting it's primarily suited for investors with a very high risk tolerance.
Oklo Inc (OKLO) Shares Gap Down to $55.15 on Mar 24
Oklo Inc (OKLO) shares experienced a 1.97% drop in mid-day trading on March 24, gapping down to $55.15. Despite this, the stock remains significantly above its 52-week low. Wall Street analysts maintain an "Outperform" status for OKLO, predicting an average upside of 80.43% from its current price.
How Oklo’s DOE milestone advanced its push into domestic isotope production
Oklo, a company focused on advanced fission, achieved a significant milestone with the U.S. Department of Energy (DOE) for the production of actinium-225, a critical medical isotope. This accomplishment signals Oklo's growing role in domestic isotope production, aiming to address supply chain vulnerabilities and support advanced nuclear technologies. The development highlights the company's progress in expanding its capabilities beyond energy generation to include medical isotope manufacturing.
Should You Buy Oklo Stock While It's Below $55?
Oklo, a company developing small, modular nuclear plants, secured a significant deal with Meta Platforms to provide 1.2 gigawatts of electricity, yet its stock is down nearly 70% from its high. While there's potential for future growth in the nuclear energy sector, Oklo is still in its infancy with revenue years away, making it a high-risk investment better suited for those with a high risk tolerance.
OKLO Posts 2025 Results: Time to Buy or Stay on the Sidelines?
OKLO's 2025 results show a company transitioning from development to execution, as the global energy landscape increasingly favors nuclear power amid fossil fuel volatility. Strategic partnerships with Meta Platforms and Centrus Energy, along with strong policy tailwinds, position OKLO for long-term growth in the next-generation nuclear sector. However, a high valuation and significant capital expenditure requirements suggest investors should approach with caution.
OKLO Posts 2025 Results: Time to Buy or Stay on the Sidelines?
Oklo Inc. (OKLO) released its full-year 2025 results, highlighting its transition into a deployment-focused company amid increasing favorable conditions for nuclear power. The company has made significant progress, including breaking ground on its Aurora powerhouse, securing a 1.2 GW partnership with Meta Platforms, and strengthening its fuel strategy with Centrus Energy. Despite a volatile stock performance and current premium valuation, OKLO's alignment with energy security needs, strong policy tailwinds, and integrated platform position it for long-term growth, though Zacks currently rates it a "Hold" due to execution risks and delayed revenue generation.
A Look At Oklo (OKLO) Valuation After Key Reactor And Fuel Cycle Milestones
Oklo (OKLO) has achieved significant milestones, including a U.S. Department of Energy agreement for its Aurora reactor and advancing fuel facility approvals, leading to a reassessment of its stock. Despite a recent share price decline, the company's valuation is debated, with one analyst suggesting the stock is undervalued at $112.13, while others point to rich market multiples for a pre-revenue business. The article advises investors to consider full valuation breakdowns and inherent risks.
Oklo (NYSE:OKLO) Trading Up 4.2% - Here's Why
Oklo (NYSE:OKLO) experienced a 4.2% stock price increase on Monday, trading up to $56.26 despite lower than average session volume. The company missed Q1 earnings estimates and has seen significant insider selling, yet Wall Street analysts maintain a "Moderate Buy" consensus with a price target of $86.63. Oklo specializes in advanced nuclear microreactor technology, aiming to provide carbon-free power.
OKLO Posts 2025 Results: Time to Buy or Stay on the Sidelines?
Oklo Inc. (OKLO) released its full-year 2025 results, showing a transition towards execution in the nuclear power sector, with advancements like the Aurora powerhouse and a 1.2 GW nuclear-powered campus agreement with Meta Platforms. Despite significant capital investment and a premium valuation, the company benefits from strong policy tailwinds and partnerships, positioning it well for long-term growth in an energy landscape favoring nuclear, though execution risks and delayed revenue generation warrant a cautious approach. The article suggests a "Hold" rating due to these factors.
Top 5 Nuclear Energy Stocks to Invest in for The Next 5 Years
This article lists the top five nuclear energy stocks for investment over the next five years, highlighting Oklo Inc. (NYSE:OKLO) as a key player. Oklo recently received U.S. Department of Energy approval for its Groves Isotopes Test Reactor, aiming to enhance domestic isotope production for various critical applications including medical and national security. The company is developing advanced nuclear technologies, including fast fission power plants and nuclear fuel recycling.
Prediction: Buying Oklo Inc. Stock Today Could Set You Up for Life
This article suggests that investing in Oklo Inc. (NYSE: OKLO) could be a lucrative long-term opportunity due to the surging demand for energy from the AI sector, which nuclear small modular reactors (SMRs) like Oklo's are positioned to meet. Despite its current small market cap and associated risks, the author believes Oklo's technology offers a compelling solution for AI data centers and other applications, potentially leading to significant returns for patient investors. However, it also acknowledges competition, uranium market tightness, and potential shareholder dilution as important risks.
Oklo Announces U.S. Department of Energy Approval for Nuclear Safety Design Agreement of Aurora Powerhouse at Idaho National Laboratory
Oklo Inc. announced that the U.S. Department of Energy (DOE) has approved the Nuclear Safety Design Agreement (NSDA) for its Aurora powerhouse at Idaho National Laboratory (INL). This approval marks a significant step under DOE’s Reactor Pilot Program (RPP) which aims to accelerate scalable generation capacity for advanced nuclear technology. Oklo will now proceed with DOE's review of its Preliminary Documented Safety Analysis and plans to pursue NRC licensing for future commercial operations.
Oklo provides updates on DOE, NRC approvals
Oklo has released updates on its progress with DOE and NRC approvals, including two nuclear safety design agreement (NSDA) approvals from the DOE for its Groves Isotope Test Reactor and Aurora Powerhouse, and a materials license from the NRC for its Idaho Radiochemistry Laboratory. While the company has achieved significant milestones, particularly in isotope production, it remains a few steps behind some competitors in the DOE's Reactor Pilot Program for certain projects. Oklo emphasized its current focus on construction, with the Groves reactor expected to be the first to come online.
Oklo Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:OKLO) 2026-03-17
Oklo Inc. (NYSE:OKLO) published its 2025 Q4 earnings call presentation on March 17, 2026. The company reported an EPS of -$0.27, missing estimates by $0.10, and revenue of $0.00, which met estimates. This article features the slide deck from the earnings call.
Oklo’s Atomic Alchemy Announces U.S. Department of Energy Approval for Nuclear Safety Design Agreement of its Groves Isotopes Test Reactor
Oklo Inc. announced that its subsidiary, Atomic Alchemy, has received approval from the U.S. Department of Energy (DOE) for the Nuclear Safety Design Agreement (NSDA) for its Groves Isotopes Test Reactor in Texas. This approval is a significant step in the DOE's Reactor Pilot Program, aimed at accelerating the deployment of advanced nuclear technologies and boosting domestic industrial capacity. The Groves facility is projected to achieve criticality by July 4, 2026, and will support the production of critical isotopes for various applications including medical treatments, scientific research, and national security, many of which are currently sourced internationally.
